Project HER-MES

Basic data

Title:
HER-MES
Duration:
16/04/2019 to 04/06/2020
Abstract / short description:
Randomized, double-blind, multicenter Head-to-head study of Erenumab against topiRamate - Migraine Study to assess tolerability and efficacy in a patiEnt-centered Setting (HER-MES).

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Nürnberg, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.